Evidence map›Paper›PMID 33741054›Full record

ArticleImplementation science communications2021

Evaluation of a multidisciplinary lipid clinic to improve the care of individuals with severe lipid conditions: a RE-AIM framework analysis.

Laney K Jones, Megan McMinn, David Kann, Michael Lesko, Amy C Sturm, Nicole Walters, Nan Chen, Kerrianne Fry, Ross C Brownson, Samuel S Gidding and 2 more

Open access · goldAbstract read
In one paragraph

Article in Implementation science communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Life Course Approach for Managing Familial Hypercholesterolemia.Journal of the American Heart Association · 2025
    Review
  4. Article
  5. Review
  6. Evaluation of multidisciplinary high-risk pregnancy clinic for myelomeningocele.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2024
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Laney K JonesGenomic Medicine Institute, Geisinger, Danville, PA, USA. ljones14@geisinger.edu.ORCID http://orcid.org/0000-0002-6182-5634
Megan McMinnGenomic Medicine Institute, Geisinger, Danville, PA, USA.
David KannHeart Institute, Geisinger, Danville, PA, USA.
Michael LeskoHeart Institute, Geisinger, Danville, PA, USA.
Amy C SturmGenomic Medicine Institute, Geisinger, Danville, PA, USA.
Nicole WaltersGenomic Medicine Institute, Geisinger, Danville, PA, USA.
Nan ChenDepartment of Population Health Sciences, Geisinger, Danville, PA, USA.
Kerrianne FryGenomic Medicine Institute, Geisinger, Danville, PA, USA.
Ross C BrownsonPrevention Research Center in St. Louis, Brown School at Washington University in St. Louis, St. Louis, USA.
Samuel S GiddingGenomic Medicine Institute, Geisinger, Danville, PA, USA.
Marc S WilliamsGenomic Medicine Institute, Geisinger, Danville, PA, USA.
Alanna Kulchak RahmGenomic Medicine Institute, Geisinger, Danville, PA, USA.
Geisinger Neuroscience Institute · USGeisinger Health System · USGeisinger Medical Center · USWashington University in St. Louis · US

Funding

Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
Washington University K12 Program in T4 Implementation ResearchK12HL137942 · NHLBI · WASHINGTON UNIVERSITY · PI DAVILA-ROMAN, VICTOR G. · 2017 to 2021
$3.1M
NHLBI NIH HHS K12 HL137942NHLBI NIH HHS K12HL137942NIDDK NIH HHS P30 DK056341
6 · The paper itself

Abstract

backgroundIndividuals with complex dyslipidemia, or those with medication intolerance, are often difficult to manage in primary care. They require the additional attention, expertise, and adherence counseling that occurs in multidisciplinary lipid clinics (MDLCs). We conducted a program evaluation of the first year of a newly implemented MDLC utilizing the RE-AIM (reach, effectiveness, adoption, implementation, and maintenance) framework to provide empirical data not only on program effectiveness, but also on components important to local sustainability and future generalizability.

methodsThe purpose of the MDLC is to increase the uptake of guideline-based care for lipid conditions. Established in 2019, the MDLC provides care via a centralized clinic location within the healthcare system. Primary care providers and cardiologists were invited to refer individuals with lipid conditions. Using a pre/post-study design, we evaluated the implementation outcomes from the MDLC using the RE-AIM framework.

resultsIn 2019, 420 referrals were made to the MDLC (reach). Referrals were made by 19% (148) of the 796 active cardiology and primary care providers, with an average of 35 patient referrals per month in 2019 (SD 12) (adoption). The MDLC saw 83 patients in 2019 (reach). Additionally, 50% (41/82) had at least one follow-up MDLC visit, and 12% (10/82) had two or more follow-up visits in 2019 (implementation). In patients seen by the MDLC, we found an improved diagnosis of specific lipid conditions (FH (familial hypercholesterolemia), hypertriglyceridemia, and dyslipidemia), increased prescribing of evidence-based therapies, high rates of medication prior authorization approvals, and significant reductions in lipid levels by lipid condition subgroup (effectiveness). Over time, the operations team decided to transition from in-person follow-up to telehealth appointments to increase capacity and sustain the clinic (maintenance).

conclusionsDespite limited reach and adoption of the MDLC, we found a large intervention effect that included improved diagnosis, increased prescribing of guideline-recommended treatments, and clinically significant reduction of lipid levels. Attention to factors including solutions to decrease the large burden of unseen referrals, discussion of the appropriate number and duration of visits, and sustainability of the clinic model could aid in enhancing the success of the MDLC and improving outcomes for more patients throughout the system.

Indexed as

CardiologyHyperlipidemiaImplementation scienceRE-AIM

Identifiers

PMID33741054
PMCPMC7977494
OpenAlexW3123537906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.